Bai X, Sheng Y, Tang Z, Pan J, Wang S, Tang B
J Fungi (Basel). 2023; 9(2).
PMID: 36836375
PMC: 9962652.
DOI: 10.3390/jof9020261.
Koo N, Sharma A, Narayan S
Int J Mol Sci. 2022; 23(9).
PMID: 35563397
PMC: 9103871.
DOI: 10.3390/ijms23095005.
Karthikeyan A, Joseph A, Nair B
J Genet Eng Biotechnol. 2022; 20(1):14.
PMID: 35080679
PMC: 8790952.
DOI: 10.1186/s43141-021-00290-4.
Staszczak M
Int J Mol Sci. 2021; 22(24).
PMID: 34948102
PMC: 8707610.
DOI: 10.3390/ijms222413309.
Pan M, Blattner C
Cancers (Basel). 2021; 13(4).
PMID: 33670160
PMC: 7916862.
DOI: 10.3390/cancers13040745.
Microbial Screening Based on the Mizoroki-Heck Reaction Permits Exploration of Hydroxyhexylitaconic-Acid-Producing Fungi in Soils.
Sano M, Yada R, Nomura Y, Kusukawa T, Ando H, Matsumoto K
Microorganisms. 2020; 8(5).
PMID: 32365722
PMC: 7284703.
DOI: 10.3390/microorganisms8050648.
Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction.
Beloglazkina A, Zyk N, Majouga A, Beloglazkina E
Molecules. 2020; 25(5).
PMID: 32156064
PMC: 7179467.
DOI: 10.3390/molecules25051211.
Biological and Chemical Diversity of Marine Sponge-Derived Microorganisms over the Last Two Decades from 1998 to 2017.
Cheng M, Tang X, Sun Y, Song D, Cheng Y, Liu H
Molecules. 2020; 25(4).
PMID: 32075151
PMC: 7070270.
DOI: 10.3390/molecules25040853.
Bioactive secondary metabolites from new endophytic fungus Curvularia. sp isolated from Rauwolfia macrophylla.
Kaaniche F, Hamed A, Abdel-Razek A, Wibberg D, Abdissa N, Zendah El Euch I
PLoS One. 2019; 14(6):e0217627.
PMID: 31247016
PMC: 6597039.
DOI: 10.1371/journal.pone.0217627.
Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine.
Qin J, Li X, Hunt C, Wang W, Wang H, Zhang R
Genes Dis. 2018; 5(3):204-219.
PMID: 30320185
PMC: 6176154.
DOI: 10.1016/j.gendis.2018.07.002.
Investigation of Marine-Derived Fungal Diversity and Their Exploitable Biological Activities.
Hong J, Jang S, Heo Y, Min M, Lee H, Lee Y
Mar Drugs. 2015; 13(7):4137-55.
PMID: 26133554
PMC: 4515608.
DOI: 10.3390/md13074137.
Targeting the ubiquitin pathway for cancer treatment.
Liu J, Shaik S, Dai X, Wu Q, Zhou X, Wang Z
Biochim Biophys Acta. 2014; 1855(1):50-60.
PMID: 25481052
PMC: 4312704.
DOI: 10.1016/j.bbcan.2014.11.005.
Diverse deep-sea fungi from the South China Sea and their antimicrobial activity.
Zhang X, Zhang Y, Xu X, Qi S
Curr Microbiol. 2013; 67(5):525-30.
PMID: 23736224
DOI: 10.1007/s00284-013-0394-6.
Natural product MDM2 inhibitors: anticancer activity and mechanisms of action.
Qin J, Nag S, Voruganti S, Wang W, Zhang R
Curr Med Chem. 2012; 19(33):5705-25.
PMID: 22830335
PMC: 6690201.
DOI: 10.2174/092986712803988910.
Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction.
Malloy K, Choi H, Fiorilla C, Valeriote F, Matainaho T, Gerwick W
Bioorg Med Chem Lett. 2011; 22(1):683-8.
PMID: 22104152
PMC: 3248991.
DOI: 10.1016/j.bmcl.2011.10.054.
Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.
Edelmann M, Nicholson B, Kessler B
Expert Rev Mol Med. 2011; 13:e35.
PMID: 22088887
PMC: 3219211.
DOI: 10.1017/S1462399411002031.
Therapeutic considerations for Mdm2: not just a one trick pony.
Lehman J, Eitel J, Batuello C, Mayo L
Expert Opin Drug Discov. 2009; 3(11):1309-1321.
PMID: 19738896
PMC: 2717507.
DOI: 10.1517/17460441.3.11.1309.
Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions.
Shaginian A, Whitby L, Hong S, Hwang I, Farooqi B, Searcey M
J Am Chem Soc. 2009; 131(15):5564-72.
PMID: 19334711
PMC: 2765553.
DOI: 10.1021/ja810025g.
Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous....
Mayer A, Rodriguez A, Berlinck R, Hamann M
Biochim Biophys Acta. 2009; 1790(5):283-308.
PMID: 19303911
PMC: 2735450.
DOI: 10.1016/j.bbagen.2009.03.011.